Dawn L. Hershman

Columbia University Irving Medical Center

Also affiliated with Columbia University

Economics, Econometrics and FinanceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.8Author DataRank

Indexed papers

9in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 9 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Papers

Driven by 102 papers — median percentile 21. Top paper: “Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings”.

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3842

N/A

3.0DataRank · unranked

48 citations

Charles D. Blanke, Michael LeBlanc, William E. Barlow, Riha Vaidya, Scott D. Ramsey +2 more

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Nature Cancer(2022)10.1038/s43018-022-00489-5

N/A

2.2DataRank · unranked

77 citations

Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan +21 more

Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.41720

N/A

1.5DataRank · unranked

56 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Journal of Clinical Oncology(2020)10.1200/jco.20.01399

N/A

1.0DataRank · unranked

995 citations

Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan, Daniel L. Hertz +11 more

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07172-y

N/A

0.957DataRank · unranked

24 citations

Shing Yip Lee, Cheng S. Leu, Bruce Levin, Meghna S. Trivedi, Katherine D. Crew +12 more

Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial

Contemporary Clinical Trials(2021)10.1016/j.cct.2021.106508

N/A

0.643DataRank · unranked

17 citations

Maura Harrigan, Brenda Cartmel, Leah M. Ferrucci, Fangyong Li, Courtney McGowan +12 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.18433

N/A

0.604DataRank · unranked

55 citations

Hong Xiao, Michael LeBlanc, Dawn L. Hershman, Charles D. Blanke, Joseph M. Unger

Risk of cardiovascular disease in women with and without a history of breast cancer: The Pathways Heart Study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12016

Top 40%

0.471DataRank

Top 40%4 citations

Carlos Iribarren, Romain Neugebauer, Jamal S. Rana, Mai N. Nguyen‐Huynh, Richard K. Cheng +11 more

Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae023

N/A

0.406DataRank · unranked

14 citations

Jennifer S. Ferris, Ling Chen, Shayan Dioun, John Usseglio, Koji Matsuo +4 more

Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4008

N/A

0.396DataRank · unranked

13 citations

Riha Vaidya, Cathee Till, William E. Barlow, Mike LeBlanc, Scott D. Ramsey +2 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0.373DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.38191

N/A

0.362DataRank · unranked

6 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +11 more

Survival After Fertility-Preserving Hormonal Therapy vs Hysterectomy for Early-Stage Endometrial Cancer

JAMA Oncology(2025)10.1001/jamaoncol.2025.2761

N/A

0.360DataRank · unranked

10 citations

Yongmei Huang, Xiao Xu, Jennifer S. Ferris, Elena B. Elkin, Chung Yin Kong +8 more

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12001

N/A

0.360DataRank · unranked

10 citations

Karla V. Ballman, Linda McCall, Pamela J. Goodwin, Anna Weiss, Linda M. Delahanty +15 more

Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.7010

N/A

0.345DataRank · unranked

9 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

JCO Clinical Cancer Informatics(2023)10.1200/cci.22.00165

N/A

0.336DataRank · unranked

4 citations

Weijia Fan, Aijin Wang, Riha Vaidya, Mary W. Redman, Scott Gettinger +5 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951

N/A

0.312DataRank · unranked

7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more

Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD

BMC Health Services Research(2022)10.1186/s12913-022-07835-4

N/A

0.284DataRank · unranked

4 citations

Ari Bell‐Brown, Karma L. Kreizenbeck, Kathryn Egan, Gary H. Lyman, Dawn L. Hershman +6 more

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618

Top 58%

0.271DataRank

Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Journal of Patient-Reported Outcomes(2020)10.1186/s41687-020-00220-x

N/A

0.269DataRank · unranked

5 citations

Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries +15 more

The Medicaid expansion of the Affordable Care Act and participation of patients with Medicaid in cancer clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6505

N/A

0.208DataRank · unranked

3 citations

Hong Xiao, Riha Vaidya, Dawn L. Hershman, Joseph M. Unger

Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy

JAMA Oncology(2026)10.1001/jamaoncol.2025.5549

N/A

0.208DataRank · unranked

3 citations

Michael J. Fisch, Salene M. W. Jones, N. Lynn Henry, Dawn L. Hershman, Joseph M. Unger

Neighborhood socioeconomic deprivation and patient-reported outcomes in symptom management trials for women with breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-024-07523-3

N/A

0.165DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael J. Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.137

N/A

0.165DataRank · unranked

2 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Trends in obesity among patients registered to SWOG cancer clinical treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.126

N/A

0.165DataRank · unranked

2 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Socioeconomic deprivation and patient-reported outcomes in symptom management trials for patients with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.158

N/A

0.165DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Use of PROMIS to capture patient reported outcomes over time for patients on I-SPY2.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.611

N/A

0.165DataRank · unranked

2 citations

Hongmei Yu, Denise M. Wolf, Nisha Acharya, Susie Brain, Carol A. Simmons +8 more

Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.368

N/A

0.165DataRank · unranked

2 citations

Amy K. Darke, Krishna S. Gunturu, Dawn L. Hershman, Michael Fisch, N. Lynn Henry +2 more

Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer

Journal of the American Medical Informatics Association(2024)10.1093/jamia/ocae190

N/A

0.165DataRank · unranked

2 citations

Anika Christofferson, Saumya Umashankar, Michelle Melisko, Paolo Castillo, Thelma Brown +15 more

Incidence of induced abortion among commercially insured pregnant patients with cancer

Contraception(2024)10.1016/j.contraception.2024.110511

N/A

0.165DataRank · unranked

2 citations

Yongmei Huang, Jenny Wu, Haley Moss, Dawn L. Hershman, Jason D. Wright +1 more

Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)

BMC Medical Informatics and Decision Making(2024)10.1186/s12911-024-02691-0

N/A

0.116DataRank · unranked

1 citations

Haeseung Yi, Jacquelyn Amenta, Nicole Collins, Anna Vaynrub, Subiksha Umakanth +34 more

Postmenopausal bleeding: Association of initial place of care with stage at diagnosis for uterine cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.10.015

N/A

0.104DataRank · unranked

1 citations

Ling Chen, Marcella Nuñez-Smith, Mitchell Clark, Jennifer S. Ferris, Yongmei Huang +3 more

Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.154

N/A

0.104DataRank · unranked

1 citations

Anna Moseley, Riha Vaidya, Hong Xiao, Michael LeBlanc, Dawn L. Hershman +1 more

A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1518

N/A

0.104DataRank · unranked

1 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +10 more

Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3567

N/A

0.104DataRank · unranked

1 citations

Veena Singh, Shing Mirn Lee, David Cieremans, Andrew B. Lassman, Dawn L. Hershman +12 more

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1525

N/A

0.104DataRank · unranked

1 citations

Aasthaa Bansal, Sean D. Sullivan, Gary H. Lyman, William E. Barlow, Kathryn B. Arnold +10 more

Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs

JCO Oncology Practice(2022)10.1200/op.22.00451

N/A

0DataRank · unranked

6 citations

Morgan RL Lichtenstein, Rohit Raghunathan, Sahil D. Doshi, Shing M. Lee, Cynthia Law +5 more

Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06614-3

N/A

0DataRank · unranked

3 citations

Vicky Ro, Simukayi Mutasa, Samuel Pan, Jianhua Hu, Meghna S. Trivedi +6 more

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab210

N/A

0DataRank · unranked

70 citations

Joseph M. Unger, Amy K. Darke, Jennifer M. Suga, James L. Wade, Peter J. Kourlas +7 more

Composition of health care contact days and mortality prediction among trial participants.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.454

N/A

0DataRank · unranked

0 citations

Cathee Till, Michael LeBlanc, Dawn L. Hershman, Joseph M. Unger, Arjun Gupta

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.526

N/A

0DataRank · unranked

0 citations

Bingshu E. Chen, Wendy R. Parulekar, Julie Lemieux, Jennifer A. Ligibel, Karen A. Gelmon +3 more

Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12024

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +8 more

Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.12007

N/A

0DataRank · unranked

0 citations

Maura Harrigan, Brenda Cartmel, Fangyong Li, Michelle Zupa, Courtney McGowan +14 more

Optimizing the implementation of systematic financial screening.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.277

N/A

0DataRank · unranked

0 citations

David DeStephano, Rohit Raghunathan, Melissa Accordino, Grace Clarke Hillyer, Justine M. Kahn +6 more

Intervention non-adherence in a pragmatic randomized trial of a standardized order entry for colony stimulating factor prescribing.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.374

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, William E. Barlow, Kathryn B. Arnold, Ari Bell‐Brown, Kate Watabayashi +5 more

Can order entry systems improve oncology practice? The TrACER Experience.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.339

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, William E. Barlow, Kathryn B. Arnold, Ari Bell‐Brown, Kate Watabayashi +5 more

Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk

UNC Libraries(2020)10.17615/wnjg-3t36

N/A

0DataRank · unranked

0 citations

Susan L. Teitelbaum, Susan E. Steck, Alfred I. Neugut, Marilie D. Gammon, Manisha Desai +7 more

Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting

JCO Clinical Cancer Informatics(2023)10.1200/cci.22.00172

N/A

0DataRank · unranked

26 citations

David DeStephano, Rohit Raghunathan, Erik Harden, Melissa Accordino, Grace Clarke Hillyer +10 more

Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk

UNC Libraries(2020)10.17615/cphq-cp16

N/A

0DataRank · unranked

0 citations

Dawn L. Hershman, Mary Beth Terry, Elizabeth Shane, Serge Cremers, Laura Reimers +9 more

Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad055

N/A

0DataRank · unranked

15 citations

Kate Watabayashi, Debbie Delaney, Ruth C. Carlos, Shelby L. Langer, Joseph M. Unger +6 more

Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06997-x

N/A

0DataRank · unranked

14 citations

Marilyn L. Kwan, Carlos Iribarren, Richard K. Cheng, Romain Neugebauer, Jamal S. Rana +11 more

Black-White differences in uterine cancer symptomatology and stage at diagnosis

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.029

N/A

0DataRank · unranked

9 citations

Ling Chen, Marcella Nuñez-Smith, Mitchell Clark, Jennifer S. Ferris, Dawn L. Hershman +2 more

The association of patient fatigue and outcomes in advanced cancer: An analysis of four SWOG treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.140

N/A

0DataRank · unranked

0 citations

Amy K. Darke, Katherine A. Guthrie, Jeff A. Sloan, Joseph M. Unger, Dawn L. Hershman +4 more

Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps12126

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Amy K. Darke, Joseph M. Unger, Mina S. Sedrak, Barbara Segarra-Vázquez +9 more

Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad053

N/A

0DataRank · unranked

1 citations

Cathee Till, Jessica Hwang, Kathryn B. Arnold, Michael LeBlanc, Dawn L. Hershman +2 more

374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.552

N/A

0DataRank · unranked

1 citations

Saumya Umashankar, Muneeb M. Musthafa, Thomas Jones, Kasey Blevins, Timothy D. Brown +15 more

Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12003

N/A

0DataRank · unranked

11 citations

Joseph M. Unger, Dawn L. Hershman, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan +9 more

Onset of cardiovascular disease risk factors in women with and without a history of breast cancer: The Pathways Heart Study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12017

N/A

0DataRank · unranked

0 citations

Carlos Iribarren, Romain Neugebauer, Jamal S. Rana, Mai N. Nguyen‐Huynh, Richard K. Cheng +11 more

Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer

Research Square(2023)10.21203/rs.3.rs-2675372/v1

N/A

0DataRank · unranked

2 citations

Marilyn L. Kwan, Carlos Iribarren, Richard K. Cheng, Romain Neugebauer, Jamal S. Rana +11 more

Association between medication burden and acute care use in older metastatic prostate cancer patients on androgen receptor signaling inhibitors

Cancer(2025)10.1002/cncr.70163

N/A

0DataRank · unranked

0 citations

Rohit Raghunathan, Karie Runcie, Margaux Wooster, Shikun Wang, Jason D. Wright +4 more

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00968

N/A

0DataRank · unranked

27 citations

Robyn D. Gartrell, Margueritta El Asmar, Shuobo Boboila, Thomas D. Hart, Yan Lu +13 more

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038

Top 100%

0DataRank

Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6527

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, William E. Barlow, Michael LeBlanc, Scott D. Ramsey +2 more

Adherence to statins and risk of cardiovascular disease in patients with breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e24065

N/A

0DataRank · unranked

0 citations

Heather Greenlee, Carlos Iribarren, Jamal S. Rana, Mai N. Nguyen‐Huynh, Richard K. Cheng +9 more

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0255

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Rohit Loomba, Jessica Hwang, Rashmi Chugh, Monica A. Tincopa +4 more

Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD—a large pragmatic trial

Supportive Care in Cancer(2023)10.1007/s00520-023-08056-z

N/A

0DataRank · unranked

0 citations

Aasthaa Bansal, Sean D. Sullivan, Kathryn B. Arnold, William E. Barlow, Dawn L. Hershman +3 more

Mixed-methods analysis of physician genomic confidence in the pre-implementation phase of the cluster randomized trial evaluating genomic tumor boards (SWOG S2108CD, NCT05455606).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.439

N/A

0DataRank · unranked

0 citations

Jens Rueter, Joseph M. Unger, Kathryn B. Arnold, Sarah Colby, Alissa Michel +8 more

Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.12019

N/A

0DataRank · unranked

3 citations

Anna Moseley, Kathryn B. Arnold, Grace Clarke Hillyer, Julie R. Gralow, N. Lynn Henry +4 more

Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat

medRxiv(2020)10.1101/2020.04.23.20066928

N/A

0DataRank · unranked

5 citations

Qingfei Pan, Cody Chiuzan, Maika Onishi, Mariano J. Alvarez, Erin Honan +17 more

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

Cancer Chemotherapy and Pharmacology(2020)10.1007/s00280-020-04030-2

N/A

0DataRank · unranked

24 citations

Allison L. Brodsky, Joseph A. Sparano, Stephanie V. Blank, Mimi Kim, Dawn L. Hershman +6 more

Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.17517

N/A

0DataRank · unranked

53 citations

Caryn M. St. Clair, June Y. Hou, F. Khoury Collado, Dawn L. Hershman, Jason D. Wright +2 more

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa034

N/A

0DataRank · unranked

114 citations

Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari +4 more

Effects of vitamin D supplementation on a deep learning–based mammographic evaluation in SWOG S0812

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae042

N/A

0DataRank · unranked

4 citations

Garnet L. Anderson, Simukayi Mutasa, Dawn L. Hershman, Mary Beth Terry, Parisa Tehranifar +18 more

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Cancer(2024)10.1002/cncr.35560

N/A

0DataRank · unranked

2 citations

Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun +11 more

The cost of doing business: Drug costs in federally sponsored cancer clinical trials.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.10

N/A

0DataRank · unranked

2 citations

Hong Xiao, Riha Vaidya, Sara Ashley Threlkel, Matthew Chansky, Allison Hayes +3 more

Multilevel factors associated with delays to neoadjuvant chemotherapy among young adults with operable breast cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11091

N/A

0DataRank · unranked

0 citations

Margaux Wooster, David DeStephano, Sarah Harkins, Shikun Wang, Jason D. Wright +4 more

Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study

PLoS ONE(2024)10.1371/journal.pone.0310531

Top 100%

0DataRank

Top 100%0 citations

Noel Pimentel, Monika A. Izano, Carlos Iribarren, Jamal S. Rana, Mai N. Nguyen‐Huynh +10 more

Patient interest in clinical trials and remote technology among a diverse oncology patient population.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.389

N/A

0DataRank · unranked

0 citations

Alissa Michel, Khadija Faheem, Erik Harden, Melissa Accordino, Melissa Beauchemin +3 more

The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non–small cell lung cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf236

N/A

0DataRank · unranked

4 citations

Michael May, Prashasti Agrawal, Jonathan Lee, Benjamin May, Xin Ma +11 more

AYA-NAV, A Patient-Informed, Tailored Needs Navigation Intervention for Adolescents and Young Adults With Cancer: A Pilot Study

Cancer Control(2025)10.1177/10732748251409888

N/A

0DataRank · unranked

2 citations

Rohit Raghunathan, Sabrina Alvarado, Stephen Crespo, Kathleen D. Gallagher, Rebekah Angove +11 more

A mixed-methods study characterizing experiences of medical oncologists’ use of gonadotropin-releasing hormone agonists for treatment of breast cancer

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07734-2

N/A

0DataRank · unranked

1 citations

Bo Hu, Dinorah Martinez Tyson, Carley Geiss, Susan T. Vadaparampil, Heather Jim +5 more

Impact of pre-existing diabetes mellitus on acute care use in older patients with metastatic prostate cancer on androgen receptor signaling inhibitors.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.119

N/A

0DataRank · unranked

0 citations

Rohit Raghunathan, Karie Runcie, Shikun Wang, Jason D Wright, Alexander Z. Wei +3 more

Association of food insecurity and financial hardship with healthcare utilization among adults with cancer treated in a large, urban cancer center.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e13579

N/A

0DataRank · unranked

0 citations

Claire Sathe, David DeStephano, Hua‐Jay J. Cherng, Justine M. Kahn, Jason D. Wright +3 more

Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women

npj Breast Cancer(2025)10.1038/s41523-025-00804-0

N/A

0DataRank · unranked

0 citations

Bo Qin, Marc A. Emerson, Etienne X. Holder, Matthew R. Dunn, Shromona Sarkar +21 more

Association between hyperglycemia and the development of chemotherapy induced peripheral neuropathy among patients with breast cancer in the control trial

Breast Cancer Research(2025)10.1186/s13058-025-01984-0

N/A

0DataRank · unranked

0 citations

Khadija Faheem, Rohit Raghunathan, Margaux Wooster, Dawn L. Hershman, Melissa Accordino +1 more

Improving postoperative opioid stewardship in cancer-related surgery: Impact of a pill-dispensing system on disposal and refill rates.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.486

N/A

0DataRank · unranked

0 citations

Jacob C. Cogan, Sarah Schneringer, Melissa Accordino, Bret Taback, Melissa Beauchemin +3 more

Association of polypharmacy with acute care utilization in older adults receiving androgen receptor signaling inhibitors for metastatic prostate cancer.

JCO Oncology Practice(2025)10.1200/op.2025.21.10_suppl.518

N/A

0DataRank · unranked

0 citations

Rohit Raghunathan, Margaux Wooster, Karie Runcie, Shikun Wang, Jason D Wright +4 more

Impact of a hospital specialty pharmacy in partnership with a free-standing care coordination organization on time to delivery and receipt of oral anticancer drugs.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.43

N/A

0DataRank · unranked

2 citations

Morgan RL Lichtenstein, Rohit Raghunathan, Sahil D. Doshi, Cynthia Law, Melissa Accordino +4 more

Factors associated with failure to receive oral anticancer drugs.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.41

N/A

0DataRank · unranked

2 citations

Morgan RL Lichtenstein, Melissa Beauchemin, Rohit Raghunathan, Cynthia Law, Melissa Accordino +4 more

Inequity in location and quality of death of advanced cancer patients by immigrant status.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12036

N/A

0DataRank · unranked

0 citations

Megan Johnson Shen, Holly G. Prigerson, Andreea Dinicu, Alfred I. Neugut, Jason D Wright +3 more

Preference-weighted quality of life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.144

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, Joseph M. Unger, Dawn L. Hershman, Daniel Maeng +2 more

Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.12018

N/A

0DataRank · unranked

2 citations

Joseph M. Unger, Heather Greenlee, Jillian L. Capodice, Danika L. Lew, Amy K. Darke +5 more

Incorporating systematic financial screening into the electronic health record.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.184

N/A

0DataRank · unranked

2 citations

Elena B. Elkin, Jason D. Wright, Rita Kukafka, Dawn L. Hershman, Justine M. Kahn +1 more

Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.34445

N/A

0DataRank · unranked

10 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs.

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.6

N/A

0DataRank · unranked

4 citations

Melissa Beauchemin, Rohit Raghunathan, Sahil D. Doshi, Cynthia Law, Melissa Accordino +4 more

New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac170

N/A

0DataRank · unranked

8 citations

Rohit Raghunathan, Melissa Beauchemin, Melissa Accordino, Yongmei Huang, Elena B. Elkin +4 more

Data Quality of Chemotherapy-Induced Nausea and Vomiting Documentation

Applied Clinical Informatics(2021)10.1055/s-0041-1728698

N/A

0DataRank · unranked

8 citations

Chunhua Weng, Lillian Sung, Adrienne Pichon, Maura Abbott, Dawn L. Hershman +2 more

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab022

N/A

0DataRank · unranked

26 citations

Alfred I. Neugut, Anna Moseley, Kathryn B. Arnold, Julie R. Gralow, N. Lynn Henry +4 more

Dawn L. Hershman

Indexed papers

Top data-sharing exemplar

Papers